Journals / art / 2021 / Cilt: 36 - Sayı: 2

A probiotic intervention on pain hypersensitivity and microbiota composition in patients with osteoarthritis pain: Study protocol for a randomized controlled trial

Journal
art
Pages
296–301
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Group by time effects will be compared using mixed-model analysis of variance.Conclusion: A reduction in pain hypersensitivity in patients with knee OA-related pain could suggest an involvement of microbiota, or part of it, in chronic pain state mechanisms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to examine the effects of probiotics on pain hypersensitivity at the end of a six-week intervention program in patients with osteoarthritis (OA)-related pain.Patients and methods: This double-blind randomized controlled clinical trial with two parallel arms will be conducted between January 2021 and July 2022.
📊
Key Findings & Data:At least 30 participants (age range, 50 to 90 years) of both sexes with a diagnosis of symptomatic hip or knee (Kellgren-Lawrence scale ≥3) will be recruited in each arm (total n=60) to achieve adequate statistical power in the analyses.
💡
Conclusion & Impact:Group by time effects will be compared using mixed-model analysis of variance.Conclusion: A reduction in pain hypersensitivity in patients with knee OA-related pain could suggest an involvement of microbiota, or part of it, in chronic pain state mechanisms.
🔬Design:Modeling & Simulation
📍Scope:2021 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: This study aims to examine the effects of probiotics on pain hypersensitivity at the end of a six-week intervention program in patients with osteoarthritis (OA)-related pain.Patients and methods: This double-blind randomized controlled clinical trial with two parallel arms will be conducted between January 2021 and July 2022. At least 30 participants (age range, 50 to 90 years) of both sexes with a diagnosis of symptomatic hip or knee (Kellgren-Lawrence scale ≥3) will be recruited in each arm (total n=60) to achieve adequate statistical power in the analyses. The intervention will be administered for six weeks followed by a four-week follow-up period. The experimental group will receive a probiotic product plus the usual medical care. The control group will receive a probiotical sham plus the usual medical care. Assessment points will be measured at baseline, end of intervention, and one-month post-intervention. The outcomes of this intervention will be a change in visual analog scale pain and the gut microbiota composition. Group by time effects will be compared using mixed-model analysis of variance.Conclusion: A reduction in pain hypersensitivity in patients with knee OA-related pain could suggest an involvement of microbiota, or part of it, in chronic pain state mechanisms.

🔖

Cite This Article

PEDERSINI, P., SAVOLDI, M., BERJANO, P., E, J. H. V. (2021). A probiotic intervention on pain hypersensitivity and microbiota composition in patients with osteoarthritis pain: Study protocol for a randomized controlled trial. art, Cilt: 36 - Sayı: 2, 296–301. https://ajindex.com/articles/351609

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Villafañe JH. Does “time heal all wounds” still have a future in osteoarthritis? Clin Exp Rheumatol 2018;36:513
  2. Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet 2015;386:376-87
  3. Villafañe JH, Valdes K, Pedersini P, Berjano P. Osteoarthritis: a call for research on central pain mechanism and personalized prevention strategies. Clin Rheumatol 2019;38:583-4
  4. Kalinkovich A, Livshits G. A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies. Semin Arthritis Rheum 2019;49:474-84
  5. Lorenzo D, GianVincenzo Z, Carlo Luca R, Karan G, Jorge V, Roberto M, et al. Oral-Gut Microbiota and Arthritis: Is There an Evidence-Based Axis? J Clin Med 2019;8:1753
  6. Villafañe JH, Drago L. What is the site of pain osteoarthritis? A triple gut-brain-joint microbioma axis. Clin Exp Rheumatol 2019;37:20-1
  7. Mukhtar K, Nawaz H, Abid S. Functional gastrointestinal disorders and gut-brain axis: What does the future hold? World J Gastroenterol 2019;25:552-66
  8. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006;440:1073-7
  9. Biver E, Berenbaum F, Valdes AM, Araujo de Carvalho I, Bindels LB, Brandi ML, et al. Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Res Rev 2019;55:100946
  10. Lei M, Guo C, Wang D, Zhang C, Hua L. The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial. Benef Microbes 2017;8:697-703
  11. Villafañe JH, Cleland JA, Fernandez-de-Las-Peñas C. Bilateral sensory effects of unilateral passive accessory mobilization in patients with thumb carpometacarpal osteoarthritis. J Manipulative Physiol Ther 2013;36:232-7
  12. Johnson C, Green B. Submitting manuscripts to biomedical journals: common errors and helpful solutions. J Manipulative Physiol Ther 2009;32:1-12
  13. Pedersini P, Valdes K, Cantero-Tellez R, Cleland JA, Bishop MD, Villafañe JH. The effects of neurodynamic mobilizations on pain hypersensitivity in patients with hand osteoarthritis compared to robotic assisted mobilization: A randomized clinical trial. Arthritis Care Res 2019. [Online ahead of print] 14. Goode AP, Shi XA, Gracely RH, Renner JB, Jordan JM.